← FDA DRUG APPROVALS

FDA ANDA · ANDA074221

EMBELINE

Sponsor: HIKMA

APPLICATION
ANDA074221
TYPE
ANDA
ORIGINAL APPROVAL
1995-03-31
LATEST ACTION
2019-02-13
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

EMBELINEDiscontinued
CLOBETASOL PROPIONATE 0.05% · OINTMENT · TOPICAL

Approval history

2019-02-13Manufacturing (CMC) · Supplement 8AP
2000-06-27Manufacturing (CMC) · Supplement 6AP
1999-01-21Manufacturing (CMC) · Supplement 5AP
1998-11-05Manufacturing (CMC) · Supplement 3AP
1998-11-05Manufacturing (CMC) · Supplement 1AP
1998-11-05Labeling · Supplement 4AP
1998-11-05Manufacturing (CMC) · Supplement 2AP
1995-03-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →